Impact Biomedical (IBO) Long-Term Deferred Tax (2024)

Impact Biomedical (IBO) has reported Long-Term Deferred Tax for 1 consecutive years, with $4.4 million the latest figure, recorded in Q4 2024.

• For the quarter ending Q4 2024, Long-Term Deferred Tax changed N/A year-over-year to $4.4 million; the trailing twelve-month figure through Dec 2024 stood at $4.4 million (changed N/A YoY), and the FY2024 full-year result was $4.4 million, changed N/A from the prior year.
• Long-Term Deferred Tax steadied at $4.4 million in Q4 2024 per IBO's latest filing.
• Across five years, Long-Term Deferred Tax topped out at $4.4 million in Q4 2024 and bottomed at $4.4 million in Q4 2024.